IL1B and Alzheimer disease: PF mediates neuroprotective effects such as reduction of neuroinflammation, reduction of amyloid β plaque load, and decreased expression of IL-1β and TNF-α in a transgenic mouse model of AD by activating adenosine A1R [31].